检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王小京 陈小情 李爱玲 吴友莉 阎晓初 卞修武 段光杰 Wang Xiaojing;Chen Xiaoqing;Li Ailing;Wu Youli;Yan Xiaochu;Bian Xiuwu;Duan Guangjie(Department of Pathology,the First Affiliated Hospital,Army Medical University,Chongqing 400038,China)
机构地区:[1]陆军军医大学第一附属医院病理科,重庆400038
出 处:《中华泌尿外科杂志》2025年第3期226-227,共2页Chinese Journal of Urology
基 金:科技部国家重点研发计划(2021YFF1201005)。
摘 要:ALK重排肾细胞癌(ALK-RCC)是第5版WHO泌尿和男性生殖器官肿瘤分类新纳入的一种分子定义的肾癌,非常罕见。因其临床症状无特异性,组织病理形态多样,准确诊断困难。本文报道1例形态和免疫表型均酷似乳头状肾细胞癌的ALK-RCC。患者根治术后组织标本经二代测序发现EML4-ALK基因融合,补做免疫组化染色ALK蛋白阳性才得以确诊。采用ALK抑制剂克唑替尼靶向治疗,随访17个月未见复发转移。Anaplastic lymphoma kinase(ALK)rearranged renal cell carcinoma(ALK-RCC)is an exceedingly rare malignancy,recently classified as a distinct molecular entity in the 5th edition of the WHO classification for urinary and male genital tumors.Due to its non-specific clinical symptoms and diverse histopathological patterns,accurate diagnosis is difficult.This paper reports a case of ALK-RCC with morphology and immunophenotype resembling papillary renal cell carcinoma.After second-generation sequencing,EML4-ALK gene fusion was found,and positive staining for ALK was confirmed by immunohistochemistry subsequently.Following informed consent from the patient,targeted therapy with crizotinib was initiated.During a 17-month follow-up period,no recurrence or metastasis was observed.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.179